ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Palbociclib Capsule shortage

To Be Discontinued  2 presentations · 1 manufacturers · first FDA posting 2026-04-22 · last update 2026-04-22

Manufacturers: Pfizer Inc.

Stated reasons (per FDA): Not stated

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Ibrance, Capsule, 75 mg (NDC 0069-0187-21)Pfizer Inc.To Be Discontinued
 —Discontinuation of the manufacturing of the capsule presentation. 75 mg Tablet NDC 0069-0284-03 will continue to be manufactured.Posted 04/22/2026
Updated 04/22/2026
Discontinued 04/22/2026
Ibrance, Capsule, 100 mg (NDC 0069-0188-21)Pfizer Inc.To Be Discontinued
 —Discontinuation of the manufacturing of the capsule presentation. 100 mg Tablet NDC 0069-0486-03 will continue to be manufactured.Posted 04/22/2026
Updated 04/22/2026
Discontinued 04/22/2026

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)